ClinicalTrials.Veeva

Menu

Reuse of Intermittent Urethral Catheters

W

Wellspect HealthCare

Status

Completed

Conditions

Intermittent Urethral Catheterization

Treatments

Device: LoFric catheters

Study type

Interventional

Funder types

Industry

Identifiers

NCT02129738
LOF-0028

Details and patient eligibility

About

The purpose of this study is to investigate and document real life safety and satisfaction of re-use of urethral catheters for intermittent self catheterization. The study will collect re-used catheters from included patients and compare those to a control group with regard to bacterial contamination and mechanical properties. A four week prospective evaluation will follow where the patients will be given catheters intended for single-use.

Enrollment

39 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Provision of informed consent

  • Female and/or male aged 18 years and over

  • Intermittent self-catheterization as primary bladder management method, defined as a normal catheterization frequency of at least 4 times daily

  • Reuse of the same silicon, rubber (latex) or plastic (e.g. vinyl, PVC) catheter

  • Accustomed intermittent catheterization user, defined as intermittent catheterization use for at least 3 months

  • Able to use catheters of size:

    40 cm, CH12 or CH14; 16'', FR12 or FR14; 15 cm, CH10 or CH12; 6'', FR10 or FR12;

Exclusion criteria

  • Antibiotic treatment within 4 weeks prior study inclusion
  • Drug or alcohol abuse or other disease of addiction
  • Immunocompromising diseases or medications
  • Known urological/renal anatomical abnormalities with potential impact on subject´s compliance as judged by the investigator
  • Diagnosis of severe fecal incontinence that may compromise study participation as judged by the investigator
  • Involvement in the planning and conduct of the study (applies to both Wellspect HealthCare staff and staff at the study site)
  • Previous enrollment in the present study
  • Simultaneous participation in another clinical study that may interfere with the present study, as judged by the investigator
  • Severe non-compliance to protocol as judged by the investigator and/or Wellspect HealthCare

Trial design

Primary purpose

Supportive Care

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

39 participants in 1 patient group

LoFric
Experimental group
Description:
LoFric catheters
Treatment:
Device: LoFric catheters

Trial contacts and locations

7

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems